Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gentle back zaps may help kids with cerebral palsy move easier

NCT ID NCT07516067

Symptom relief Sponsor: Martin Piazza Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a mild, non-invasive electrical stimulation on the back (transcutaneous spinal cord stimulation) can reduce spasticity—stiff, tight muscles—in children with cerebral palsy. Researchers will compare spinal cord activity in 30 children with CP and typically developing kids. Participants will do movement exercises and receive gentle stimulation that feels like a light tap, while doctors measure changes in muscle stiffness and nerve signals.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcutaneous spinal cord stimulation (tSCS) device
What this could lead to
If it works, this could offer a non-invasive way to ease muscle stiffness and improve movement in children with cerebral palsy.
What could go wrong
This is a small, early-stage study (30 participants) focused on measuring spinal cord activity, not yet proving long-term benefit. The stimulation may not reduce spasticity for all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 17 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: A. Patient-Participant Group (Children with Cerebral Palsy) * Children aged 5 to 17 years with a confirmed diagnosis of cerebral palsy. * Gross Motor Function Classification System (GMFCS) Levels I to IV, able to walk with or without assistance (walker or cane). This classification will have been completed by Dr. Martin Piazza and his Movement Disorders clinic team. * Stable medical condition without recent surgeries or interventions that could affect motor function. * Must be able to communicate basic needs and follow simple instructions. * Provision of informed consent by a parent or legal guardian, with assent from the child as appropriate. B. Control Group (Children without Neurological Diagnoses) * Children aged 5 to 17 years with no history of neurological diagnoses. * Must be fully ambulatory without assistance. * Must be able to communicate basic needs and follow simple instructions. * Provision of informed consent by a parent or legal guardian, with assent from the child as appropriate. Exclusion Criteria: * Presence of implanted medical devices (e.g., baclofen pumps, deep brain stimulators) that may interfere with TSCS. * Severe scoliosis or spinal deformities that could affect the delivery of tSCS. * Uncontrolled epilepsy or a history of frequent seizures. * Severe cognitive impairments limiting the ability to comply with study procedures. * Skin conditions or open wounds at the site of stimulation. * Participation in other interventional studies that may confound results. * Any serious disease or disorder (e.g. cancer, severe cardiac or respiratory disease, etc.) that could affect ability to participate in this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy Muscle Spasticity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebral palsy Spasticity

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • UPMC Children's Hospital of Pittsburgh

    RECRUITING

    Pittsburgh, Pennsylvania, 15224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.